Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | F3Y25 | — |
an expired dose of Havrix was administered to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 13-year-old female patient who received HAV (Havrix) (batch number F3Y25, expiry date 15-FEB-2025) for prophylaxis. On 25-FEB-2025, the patient received Havrix. On 25-FEB-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: an expired dose of Havrix was administered to a patient). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 27-FEB-2025 The operations supervisor reported that an expired dose of Havrix was administered to a patient, which led to expired vaccine used The Vaccine Administration Facility is the same as Primary Reporter.